Literature DB >> 15330330

True gynecomastia in congenitally HIV-infected children treated with antiretroviral agents.

R Manfredi1, L Calza, F Chiodo.   

Abstract

Gynecomastia is an emerging untoward effect of HIV-infected patients treated with antiretroviral agents, but frequency, pathogenesis, relationship to single anti-HIV compounds, evolution, and outcome are still under investigation. We report the first two cases of true gynecomastia observed in prepubertal congenitally-infected boys, and clinical, antiretroviral, metabolic, hormonal, virological, and immunological aspects.

Entities:  

Mesh:

Year:  2004        PMID: 15330330     DOI: 10.1179/joc.2004.16.3.303

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


  2 in total

1.  Who Gets Severe Gynecomastia Among HIV-infected Children in the United Kingdom and Ireland?

Authors:  Julia Kenny; Katja Doerholt; Di M Gibb; Ali Judd
Journal:  Pediatr Infect Dis J       Date:  2017-03       Impact factor: 2.129

2.  Efavirenz-induced gynecomastia in a prepubertal girl with human immunodeficiency virus infection: a case report.

Authors:  Mette S van Ramshorst; Magdeline Kekana; Helen E Struthers; James A McIntyre; Remco P H Peters
Journal:  BMC Pediatr       Date:  2013-08-13       Impact factor: 2.125

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.